591 related articles for article (PubMed ID: 15362796)
1. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
[TBL] [Abstract][Full Text] [Related]
2. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
Holtmann G; Layer P; Goebell H
Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
[TBL] [Abstract][Full Text] [Related]
3. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
4. The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2-receptor antagonist after bleeding from a gastric ulcer.
Ozawa T; Yoshikawa N; Tomita T; Akita Y; Mitamura K
J Gastroenterol; 2003; 38(9):844-8. PubMed ID: 14564629
[TBL] [Abstract][Full Text] [Related]
5. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
6. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
Tofil NM; Benner KW; Fuller MP; Winkler MK
J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
[TBL] [Abstract][Full Text] [Related]
7. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
8. The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.
Törüner M; Bektaş M; Cetinkaya H; Soykan I; Ozden A
Turk J Gastroenterol; 2004 Dec; 15(4):225-8. PubMed ID: 16249975
[TBL] [Abstract][Full Text] [Related]
9. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole versus histamine H2 receptor antagonists in the treatment of acute upper non-variceal bleeding.
Mohamed SA; al Karawi MA
Hepatogastroenterology; 1996; 43(10):863-5. PubMed ID: 8884305
[TBL] [Abstract][Full Text] [Related]
11. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial.
Uedo N; Takeuchi Y; Yamada T; Ishihara R; Ogiyama H; Yamamoto S; Kato M; Tatsumi K; Masuda E; Tamai C; Yamamoto S; Higashino K; Iishi H; Tatsuta M
Am J Gastroenterol; 2007 Aug; 102(8):1610-6. PubMed ID: 17403076
[TBL] [Abstract][Full Text] [Related]
12. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
[TBL] [Abstract][Full Text] [Related]
13. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
Mazure PA
Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
[No Abstract] [Full Text] [Related]
14. [Do proton pump inhibitors after endoscopic control of acute ulcer hemorrhage have an advantage over H2 receptor antagonists?].
Prassler R; Hendrich H; Barnert J; Richter G; Fleischmann R; Wienbeck M
Z Gastroenterol; 1995 Aug; 33(8):431-4. PubMed ID: 7483734
[TBL] [Abstract][Full Text] [Related]
15. The effect of over-the-counter ranitidine 75 mg on night-time heartburn in patients with erosive oesophagitis on daily proton pump inhibitor maintenance therapy.
Vakil N; Guda N; Partington S
Aliment Pharmacol Ther; 2006 Mar; 23(5):649-53. PubMed ID: 16480404
[TBL] [Abstract][Full Text] [Related]
16. The effects of omeprazole, a proton pump inhibitor, on early gastric stagnation after a pylorus-preserving pancreaticoduodenectomy: results of a randomized study.
Toyota N; Takada T; Yasuda H; Amano H; Yoshida M; Isaka T; Hijikata H; Takada K
Hepatogastroenterology; 1998; 45(22):1005-10. PubMed ID: 9755997
[TBL] [Abstract][Full Text] [Related]
17. Stress ulcer prophylaxis in patients on ventilator.
Darlong V; Jayalakhsmi TS; Kaul HL; Tandon R
Trop Gastroenterol; 2003; 24(3):124-8. PubMed ID: 14978984
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the therapeutic effects and acid suppression of H2-receptor antagonist and proton pump inhibitor in patients with gastric body ulcer--a prospective controlled trial].
Takeyama Y; Matsui T; Yao T; Motomura A; Arita M; Okada M; Tanaka K; Imamura T; Hatakeyama S
Nihon Shokakibyo Gakkai Zasshi; 1999 May; 96(5):502-10. PubMed ID: 10368993
[TBL] [Abstract][Full Text] [Related]
19. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Buzás GM; Józan J
Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
[TBL] [Abstract][Full Text] [Related]
20. Effect of H2-receptor antagonists on bile acid metabolism.
Shindo K; Fukumura M
J Investig Med; 1995 Apr; 43(2):170-7. PubMed ID: 7735920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]